TMTakamitsu Masuda

Takamitsu Masuda

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Takamitsu Masuda has a total of 69 co-authors. Here are the top co-authors by number of shared publications:

  • Taku Inaniwa

    Department of Accelerator and Medical Physics, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Chiba, 263-8555, JAPAN

    6 shared publications
  • Teiji Nishio

    Medical Physics Laboratory, Division of Health Science, Graduate School of Medicine, The University of Osaka, 1-7, Yamadaoka, Suita-shi, Osaka, Osaka, 565-0871, JAPAN

    5 shared publications
  • Makoto Arimoto

    Faculty of Mathematics and Physics, Institute of Science and Engineering, Kanazawa University, Kakuma, Kanazawa, Ishikawa 920-1192, Japan

    4 shared publications
  • Kumiko Karasawa

    Department of Radiation Oncology, School of Medicine, Tokyo Women's Medical University, 8-1, Kawadacho, Shinjuku-ku, Shinjuku-ku, Tokyo, 162-8666, JAPAN

    3 shared publications
  • Nobuyuki Kanematsu

    Department of Accelerator and Medical Physics, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, JAPAN

    3 shared publications
  • Akira Sano

    Department of Medical Physics, Graduate School of Medicine, Tokyo Women's Medical University, Shinjuku-ku, Tokyo, JAPAN

    2 shared publications

Latest Publications

  • Robustness of LET d -optimized multi-ion therapy against range and setup uncertainties: evaluation and enhancement with carbon-, oxygen-, and neon-ion beams

    by Takamitsu Masuda, Hiroaki Ikawa, Makoto Shinoto, Masashi Koto, Koki Kasamatsu, Yusuke Nomura, Nobuyuki Kanematsu, Taku Inaniwa

    Objective: The LET trilemma—an inherent conflict between target dose homogeneity, range robustness, and high dose-averaged linear energy transfer (LET d )—poses a major challenge in treatment optimization. To ensure accurate beam delivery in multi-ion therapy, this study evaluated the effects of range and setup uncertainties on LET d -optimized treatment plans and explored strategies to overcome this trilemma, framed within the phase I LET d escalation trial for head and neck cancers. Approach: Six head and neck cancer patients representing diverse tumors were selected. Multi-ion therapy plans using carbon-, oxygen-, and neon-ion beams were optimized to achieve a target LET d of 90 keV/μm (the final LET d level of the phase I trial). These plans were recalculated to incorporate uncertainties arising from stopping power ratio conversion and random daily setup variations across the 16 fractions, and their combined effects on the dose and LET d distributions were evaluated. Additionally, to explore strategies to increase plan robustness, five modified plans were evaluated for one patient identified as particularly susceptible to these uncertainties. Main results: Range uncertainty was the dominant contributor to degraded plan quality in multi-ion therapy, substantially outweighing setup uncertainty. A small, centrally located tumor was most susceptible, exhibiting dose inhomogeneity of approximately 11%, while LET d variations were approximately 3 keV/μm. The most effective strategy involved replacing the original carbon−oxygen combination with oxygen ions for two beam ports, reducing dose inhomogeneity by more than 7% while maintaining normal tissue sparing adjacent to the target. Significance: Optimization toward achieving higher LET d makes treatment plans susceptible to range uncertainty, leading to dose degradation within small, deep-seated tumors. Employing heavier ions is an effective strategy to overcome this challenge, enabling robust target coverage by leveraging their inherently higher LET d while sparing normal tissues. These findings provide a key rationale for ion selection in the design of robust multi-ion therapy.


  • Neon ion radiotherapy: physics and biology

    by Stewart Mein, Takamitsu Masuda, Koki Kasamatsu, Taku Nakaji, Yusuke Nomura, Jiayao Sun, Ken Katagiri, Yoshiyuki Iwata, Nobuyuki Kanematsu, Kota Mizushima, et al.

    Neon ion ( 20 Ne) beam radiotherapy was one of the primary particle therapy candidates investigated during the clinical trials beginning in the 1970s at the Lawrence Berkely National Laboratory (LBNL), which shut down in the early 1990s. Currently, therapeutic neon ion beams are available at only one clinical facility worldwide, the National Institutes for Quantum Science and Technology (QST) in Chiba, Japan. Recently, neon ion beams were commissioned at QST Hospital as part of the first clinical multi-ion therapy (MIT) program, which aims to improve clinical outcomes by escalating higher linear energy transfer (LET) radiation in the tumor for treating therapy-resistant disease. With the advancement of high-precision scanning delivery techniques, neon ion treatments in the present day could be delivered more safely and with greater precision compared to the first and only clinical application decades prior at LBNL using passive scattering technology. Despite their promising results, preclinical investigations of neon ions are scarce outside of Japan and further independent studies are needed. Clinically, neon ion therapy may offer benefits in treating certain malignancies by escalating LET in the tumor, but its limited availability and high costs restrict its current use and adoption. Studies have shown that 20 Ne or multi-ion mixtures ( 4 He, 12 C, 16 O and/or 20 Ne) can provide larger degrees of freedom in optimization of dose, LET and relative biological effectiveness, otherwise unattainable with other single ion techniques. Neon ion beams are under investigation in the ongoing MIT clinical trials which will establish their broader applicability. In this review, the technology, physics, radiobiology, and potential clinical applications of neon ion beams are outlined. The status of therapeutic neon ion beams is provided while discussing future research and clinical directions, including technological development of novel particle therapy delivery techniques, such as multi-ion, mini-beam, arc, and ultra-high dose rate.


  • Experimental validation of a Fisher information–based predictive framework for dose and time optimization in PET-guided online adaptive proton therapy

    by Jun Nakao, Takamitsu Masuda, Tsubasa Yamano, Toshiyuki Toshito, Teiji Nishio

    Objective: The range determination uncertainty ( σ est ) based on positron emission tomography (PET) imaging, which stems from the Poisson statistics of the detected signal, can be theoretically predicted using Fisher information. This study aims to experimentally validate a Fisher information–based predictive framework that optimizes the irradiation dose and measurement time required for reliable range verification in PET-guided online adaptive proton therapy. Approach: First, we defined a precision criterion of 1.5 σ est < 2 mm for reliable range verification. Then, using polyethylene, water, and a head and neck phantom, we determined the minimum measurement time—calculated in 2-s increments—required to satisfy this criterion at given irradiation doses (0.5 Gy and 0.1 Gy) based on Fisher information. For each condition, 5,000 PET images were generated from the measurement datasets, and the maximum likelihood estimation method was independently applied to each to determine the standard deviation of the measured range ( σ meas ). Finally, the values of σ meas were compared with those of σ est to validate the predictive framework. Main results: The values of σ meas and σ est showed consistent agreement (within approximately 0.5 mm), regardless of target properties, dose levels, and measurement times. Furthermore, the measured range uncertainty satisfied the pre-defined precision criterion of 1.5 σ meas < 2 mm under almost all of the tested conditions. Significance: This study provides the first experimental validation of the Fisher information–based predictive framework for PET-based range verification. The findings offer a rationale for integrating this framework into PET-guided online adaptive proton therapy, which will potentially enable reliable range verification with the minimum pre-irradiation dose and measurement time.

  • Open Access

    Implementation and 3D extension of dose reconstruction strategies from prompt-gamma emissions in proton therapy

    by B Foglia, C Gianoli, E De Bernardi, T Masuda, T Du, T Bortfeld, K Parodi, M Pinto

    Objective. Range and dose monitoring with secondary radiation can help minimizing the issues of range uncertainties in proton cancer therapy. Prompt gammas (PGs) have been widely investigated as a promising secondary radiation for in vivo verification. Since it can be argued that for a proper delivery of the intended treatment the most desirable quantity to assess is the dose distribution in vivo , this work aims at the reconstruction of the delivered proton dose from distributions of PG radiation. Approach. Some techniques have already been proposed in the literature to reconstruct the dose from a distribution of detected secondary radiation, mostly positron emitters. Among them, very promising methods are the analytical deconvolution approach, the evolutionary algorithm and the maximum-likelihood expectation-maximization (MLEM) algorithm. Herein, the feasibility of the application of these approaches to PG distributions at emission stage is assessed with simulated mono- and polyenergetic proton beams, irradiating homogeneous and inhomogeneous phantoms, and a realistic case of a head and neck (H&N) tumor patient. Main results. The accuracy of the reconstructed dose is evaluated via comparison with the corresponding simulated ground truth dose distributions using different metrics. For the case of 1D reconstruction on phantoms, the Δ R 80 , Δ R 50 and Δ R 10 , with Δ R % being the difference of the positions at the % of the dose maximum in the distal fall-off region between the simulated and reconstructed curves, are always less or of the order of 1 mm in absolute value. For 3D reconstruction on phantoms and on the H&N case, the γ (1%/1 mm) passing rate is always above or equal to 97%. Significance. This study demonstrates the applicability of the analytical deconvolution, the evolutionary and the MLEM algorithms to dose reconstruction from PG emissions, providing a step forward toward the final goal of real-time verification of the dose delivery for real-time adaptive particle therapy.

  • In-beam range determination using an OpenPET system for helium, carbon, oxygen, and neon ion beams

    by Jiayao Sun, Takamitsu Masuda, Hideaki Tashima, Chie Toramatsu, Akram Hamato, Taiga Yamaya, Sodai Tanaka, Koki Kasamatsu, Stewart Mein, Taku Inaniwa

    Objective. At the National Institutes for Quantum Science and Technology, helium, carbon, oxygen, and neon ion beams are utilized together in multi-ion therapy to enhance the therapeutic efficacy of charged-particle therapy. When accelerated ions traverse a medium, a fraction will undergo nuclear interactions, some of which, in turn, produce positron-emitting nuclei. This study investigates the accuracy of ion beam range determination using the annihilation photons emitted from the nuclei measured with an in-house online PET system (OpenPET). Approach. A polymethyl methacrylate phantom was irradiated separately with un-scanned helium, carbon, oxygen, and neon ion beams to 1.5 Gy physical doses at the Bragg peak. Annihilation photons were measured with OpenPET. Each irradiation was simulated using the Particle and Heavy Ion Transport code System (PHITS) to obtain the predicted annihilation photon distributions. The range of beams in the phantom was determined by comparing measured and simulated planar-integrated annihilation photon distributions (PIADs). Fisher information was used to quantify the expected accuracy of range determinations. Main results. The measured PIADs showed good agreement with the simulated PIADs for carbon, oxygen, and neon ions. However, discrepancies were observed for helium ions, likely due to uncertainties in the cross section data used in PHITS. The range was determined within an accuracy of 2 mm for four ion species for the measurement times longer than 3 min. Neon ions had the most Fisher information for measurement times shorter than 135 s, whereas beyond that, oxygen ions had the most information, offering the highest range determination accuracy. Significance. The range was determined within an accuracy of 2 mm for helium, carbon, oxygen, and neon ion beams by the OpenPET measurements of 180 s. Among the four ion species, neon ions showed the highest accuracy in range determination within 135 s, while oxygen ions performed best for measurement times beyond 135 s.


  • Design of multi-ion therapy for head and neck cancers using carbon-, oxygen-, and neon-ion beams: potential efficacy against tumor hypoxia

    by Takamitsu Masuda, Masashi Koto, Hiroaki Ikawa, Hideyuki Takei, Katsumi Aoki, Taku Nakaji, Koki Kasamatsu, Taku Inaniwa

    Objective. In order to initiate multi-ion therapy for head and neck cancers, it is necessary to predetermine the target dose-averaged linear energy transfer (LETd) prescription to the gross tumor volume (GTV). This study investigated LETd optimized treatment plans with carbon-, oxygen-, and neon-ion beams and demonstrated their potential efficacy against tumor hypoxia. Approach. Sixteen head and neck cancer patients with GTV sizes ranging from 5.5 to 143.1 cm3 were selected for this retrospective planning study. Carbon, oxygen, and neon ions were used alone or in combination with two ion species. The treatment plans were optimized to increase LETd within the GTV and to make the LETd distribution uniform while maintaining the relative biological effectiveness weighted dose distributions of conventional intensity modulated carbon-ion therapy (IMIT). The effective dose improvement rate against IMIT was then estimated by changing oxygen partial pressure within the GTV to 0 mmHg because a substantial number of anoxic cancer cells is predicted to exist in a hypoxic tumor microenvironment. Main results. The target LETd of 90 keV μm−1 was prescribable without deteriorating the dose distributions when: for example, carbon- and oxygen-ion beams were used for small tumors (around 20 cm3); oxygen-ion beams alone were used for medium tumors (around 50 cm3); and carbon- and neon-ion beams were used for large tumors (around 100 cm3). The uniformity of the LETd distributions within the GTV was about 10%. With the LETd prescription, the improvement rate of the effective dose covering 98% (i.e. D 98 % ) of the GTV against anoxic cancer cells was about 30%. Significance. For the application to the first multi-ion therapy program, the target LETd prescription to the GTV was determined to be 90 keV μm−1. If tumor hypoxia contributes to the cause of recurrence, the proposed treatment may offer better local tumor control without compromising normal tissue sparing.


  • Effects of intra-tumoral cellular heterogeneity of oxygen partial pressure on biological effectiveness of hydrogen-, helium-, carbon-, oxygen-, and neon-ion beams

    by Taku Inaniwa, Takamitsu Masuda, Nobuyuki Kanematsu

    Objective. The tumor microenvironment characterized by heterogeneously organized vasculatures causes intra-tumoral heterogeneity of oxygen partial pressure p at the cellular level, which cannot be measured by current imaging techniques. The intra-tumoral cellular p heterogeneity may lead to a reduction of therapeutic effects of radiation. The purpose of this study was to investigate the effects of the heterogeneity on biological effectiveness of H-, He-, C-, O-, and Ne-ion beams for different oxygenation levels, prescribed dose levels, and cell types. Approach. The intra-tumoral cellular p distributions were simulated with a numerical tumor model for average oxygen pressures p ¯ t ranging from 2.5 to 15 mmHg. The relative biological effectiveness (RBE)-weighted dose distributions of 3–15 Gy prescribed doses were planned for a cuboid target with the five ion species for constant p ¯ t values. Radiosensitivities of human salivary gland tumor (HSG) and Chinese hamster ovary (CHO) cells were investigated. The planned dose distributions were then recalculated by taking the p heterogeneity into account. Main results. As p ¯ t decreased and prescribed dose increased, the biological effectiveness of the ion beams decreased due to the p heterogeneity. The reduction in biological effectiveness was pronounced for lighter H- and He-ion beams compared to heavier C-, O-, and Ne-ion beams. The RBE-weighted dose in the target for HSG (CHO) cells decreased by 41.2% (44.3%) for the H-ion beam, while it decreased by 16.7% (14.7%) for the Ne-ion beam at a prescribed dose of 15 Gy under a p ¯ t of 2.5 mmHg. Significance. The intra-tumoral cellular p heterogeneity causes a significant reduction in biological effectiveness of ion beams. These effects should be considered in estimation of therapeutic outcomes.


  • Effects of cellular radioresponse on therapeutic helium-, carbon-, oxygen-, and neon-ion beams: a simulation study

    by Takamitsu Masuda, Taku Inaniwa

    Objective . Helium, oxygen, and neon ions in addition to carbon ions will be used for hypofractionated multi-ion therapy to maximize the therapeutic effectiveness of charged-particle therapy. To use new ions in cancer treatments based on the dose-fractionation protocols established in carbon-ion therapy, this study examined the cell-line-specific radioresponse to therapeutic helium-, oxygen-, and neon-ion beams within wide dose ranges. Approach . Response of cells to ions was described by the stochastic microdosimetric kinetic model. First, simulations were made for the irradiation of one-field spread-out Bragg peak beams in water with helium, carbon, oxygen, and neon ions to achieve uniform survival fractions at 37%, 10%, and 1% for human salivary gland tumor (HSG) cells, the reference cell line for the Japanese relative biological effectiveness weighted dose system, within the target region defined at depths from 90 to 150 mm. The HSG cells were then replaced by other cell lines with different radioresponses to evaluate differences in the biological dose distributions of each ion beam with respect to those of carbon-ion beams. Main results . For oxygen- and neon-ion beams, the biological dose distributions within the target region were almost equivalent to those of carbon-ion beams, differing by less than 5% in most cases. In contrast, for helium-ion beams, the biological dose distributions within the target region were largely different from those of carbon-ion beams, more than 10% in several cases. Significance. From the standpoint of tumor control evaluated by the clonogenic cell survival, this study suggests that the dose-fractionation protocols established in carbon-ion therapy could be reasonably applied to oxygen- and neon-ion beams while some modifications in dose prescription would be needed when the protocols are applied to helium-ion beams. This study bridges the gap between carbon-ion therapy and hypofractionated multi-ion therapy.


  • Denoising PET images for proton therapy using a residual U-net

    by Akira Sano, Teiji Nishio, Takamitsu Masuda, Kumiko Karasawa

    The use of proton therapy has the advantage of high dose concentration as it is possible to concentrate the dose on the tumor while suppressing damage to the surrounding normal organs. However, the range uncertainty significantly affects the actual dose distribution in the vicinity of the proton range, limiting the benefit of proton therapy for reducing the dose to normal organs. By measuring the annihilation gamma rays from the produced positron emitters, it is possible to obtain a proton induced positron emission tomography (pPET) image according to the irradiation region of the proton beam. Smoothing with a Gaussian filter is generally used to denoise PET images; however, this approach lowers the spatial resolution. Furthermore, other conventional smoothing processing methods may deteriorate the steep region of the pPET images. In this study, we proposed a denoising method based on a Residual U-Net for pPET images. We conducted the Monte Carlo simulation and irradiation experiment on a human phantom to obtain pPET data. The accuracy of the range estimation and the image similarity were evaluated for pPET images using the Residual U-Net, a Gaussian filter, a median filter, the block-matching and 3D-filtering (BM3D), and a total variation (TV) filter. Usage of the Residual U-Net yielded effective results corresponding to the range estimation; however, the results of peak-signal-to-noise ratio were identical to those for the Gaussian filter, median filter, BM3D, and TV filter. The proposed method can contribute to improving the accuracy of treatment verification and shortening the PET measurement time.


  • Extension of the ML-EM algorithm for dose estimation using PET in proton therapy: application to an inhomogeneous target

    by Takamitsu Masuda, Teiji Nishio, Akira Sano, Kumiko Karasawa

    Positron emission tomography (PET) has been used for in vivo treatment verification, mainly for range verification, in proton therapy. Evaluating the direct dose from PET measurements remains challenging; however, it is highly desirable from a clinical perspective. In this study, a method for estimating the dose distribution from the positron emitter distributions was developed using the maximum likelihood expectation maximization algorithm. The 1D spatial relationship between positron emitter distributions and a dose distribution in an inhomogeneous target was inputted into the system matrix based on a filter framework. In contrast, spatial resolution of the PET system and total variation regularization (as prior knowledge for dose distribution) were considered in the 3D image-space. The dose estimation was demonstrated using Monte Carlo simulated PET activity distributions with substantial noise in a head and neck phantom. This mimicked the single field irradiation of the spread-out Bragg peak beams at clinical dose levels. Besides the simple implementation of the algorithm, this strategy achieved a high-speed calculation (30 s for a 3D dose estimation) and accurate dose and range estimations (less than 10% and 2 mm errors at 1- σ values, respectively). The proposed method could be key for using PET for in vivo dose monitoring.